357 related articles for article (PubMed ID: 26449821)
1. Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.
De Iuliis F; Salerno G; Taglieri L; De Biase L; Lanza R; Cardelli P; Scarpa S
Tumour Biol; 2016 Mar; 37(3):3379-87. PubMed ID: 26449821
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial.
Rüger AM; Schneeweiss A; Seiler S; Tesch H; van Mackelenbergh M; Marmé F; Lübbe K; Sinn B; Karn T; Stickeler E; Müller V; Schem C; Denkert C; Fasching PA; Nekljudova V; Garfias-Macedo T; Hasenfuß G; Haverkamp W; Loibl S; von Haehling S
J Am Heart Assoc; 2020 Dec; 9(23):e018143. PubMed ID: 33191846
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up.
Giusca S; Korosoglou G; Montenbruck M; Geršak B; Schwarz AK; Esch S; Kelle S; Wülfing P; Dent S; Lenihan D; Steen H
Circ Cardiovasc Imaging; 2021 Jun; 14(6):e012459. PubMed ID: 34126756
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Biosimilar Trastuzumab with Reference Trastuzumab Activity in HER2-Positive Breast Cancer Patients.
AbdulHameed Saeed V; Mohammed NAK
Arch Razi Inst; 2023 Jun; 78(3):981-988. PubMed ID: 38028843
[TBL] [Abstract][Full Text] [Related]
5. Cardiological parameters predict mortality and cardiotoxicity in oncological patients.
Romann SW; Finke D; Heckmann MB; Hund H; Giannitsis E; Katus HA; Frey N; Lehmann LH
ESC Heart Fail; 2024 Feb; 11(1):366-377. PubMed ID: 38012070
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of cardiotoxicity during immunotherapy with Herceptin using simultaneous continuous wave Doppler depending on N-terminal pro-brain natriuretic peptide.
Knobloch K; Tepe J; Lichtinghagen R; Luck HJ; Vogt PM
Clin Med (Lond); 2007; 7(1):88-9; author reply 89. PubMed ID: 17348585
[No Abstract] [Full Text] [Related]
7. Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis.
Loo WY; Yue Y; Fan CB; Bai LJ; Dou YD; Wang M; Liang H; Cheung MN; Chow LW; Li JL; Tian Y; Qing L
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S5. PubMed ID: 23046680
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy.
Chen ZL; Jia KP; Zheng Y; Zhang N; Wang X; Tse G; Zhang ZW; Hu HL; Liu T
Ann Noninvasive Electrocardiol; 2024 Jan; 29(1):e13107. PubMed ID: 38288514
[TBL] [Abstract][Full Text] [Related]
9. Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.
Thonusin C; Osataphan N; Leemasawat K; Nawara W; Sriwichaiin S; Supakham S; Gunaparn S; Apaijai N; Somwangprasert A; Phrommintikul A; Chattipakorn SC; Chattipakorn N
J Transl Med; 2024 Apr; 22(1):398. PubMed ID: 38685030
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues.
Bracun V; Aboumsallem JP; van der Meer P; de Boer RA
Curr Oncol Rep; 2020 Jun; 22(7):67. PubMed ID: 32514994
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.
Bikiewicz A; Banach M; von Haehling S; Maciejewski M; Bielecka-Dabrowa A
ESC Heart Fail; 2021 Aug; 8(4):2397-2418. PubMed ID: 33955207
[TBL] [Abstract][Full Text] [Related]
12. The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy.
Demkow U; Biatas-Chromiec B; Stelmaszczyk-Emmel A; Radzikowska E; Wiatr E; Radwan-Rohrenschef P; Szturmowicz M
EJIFCC; 2011 Mar; 22(1):6-15. PubMed ID: 27683384
[TBL] [Abstract][Full Text] [Related]
13. Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab.
Luna-Alcala S; Espejel-Guzmán A; Lerma C; Leon P; Guerra EC; Fernández JRE; Martinez-Dominguez P; Serrano-Roman J; Cabello-Ganem A; Aparicio-Ortiz AD; Keirns C; Lerma A; Ana-Bayona MJS; Espinola-Zavaleta N
Cardiooncology; 2024 May; 10(1):32. PubMed ID: 38812020
[TBL] [Abstract][Full Text] [Related]
14. RISK SCORE MODEL FOR PREDICTING CARDIOTOXICITY IN BREAST CANCER: DIAGNOSTIC VALUE OF HIGH-SENSITIVITY CARDIAC TROPONIN T.
Dovganych NV; Kozhukhov SM; Smolanka II; Lygyrda OF; Bazyka OY; Lyalkin SA; Yarynkina OA
Probl Radiac Med Radiobiol; 2023 Dec; 28():454-467. PubMed ID: 38155141
[TBL] [Abstract][Full Text] [Related]
15. Early prediction of chemotherapy-induced cardiotoxicity.
Jones KA; Goodfield NER
J Nucl Cardiol; 2023 Oct; 30(5):2112-2113. PubMed ID: 36977898
[No Abstract] [Full Text] [Related]
16. Pulse check: Exploring the potential of the shock index as a biomarker for cancer-therapy-related cardiotoxicity in breast cancer patients.
Nohria A; Ben Zadok OI
J Nucl Cardiol; 2024 May; 35():101861. PubMed ID: 38604494
[No Abstract] [Full Text] [Related]
17. Cardiac Magnetic Resonance Imaging Findings in Human Epidermal Growth Factor Receptor 2-Targeted Therapy-Related Cardiotoxicity.
Şener YZ; Ardalı Düzgün S; Hazırolan T; Tokgözoğlu L
Anatol J Cardiol; 2023 Dec; 27(12):E38-E39. PubMed ID: 38031670
[No Abstract] [Full Text] [Related]
18. Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer Therapies.
Witteles RM
J Card Fail; 2016 Jun; 22(6):459-64. PubMed ID: 27038641
[TBL] [Abstract][Full Text] [Related]
19. Anthracycline or trastuzumab-related cardiotoxicity: do we have a predictive biomarker?
Chaudry M; Banchs J; Chavez-MacGregor M
Biomark Med; 2016; 10(3):315-28. PubMed ID: 26860187
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
